← Feed

u/Specialist_Self4672

3 theses · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$PCSAr/pennystocksBullishbullish
u/Specialist_Self4672 · 388d ago2 prior · awaiting results

Listen up – PCSA’s 120-day deadline is next week (Oct 15th)

PCSA's 120-day deadline for finalizing a binding $454M licensing deal with Intact Therapeutics expires October 15th. Two of three likely outcomes (deal completion or extension with additional payment) are bullish, while a walk-away is least probable. The stock is consolidating on low volume in anticipation of this catalyst.

At post $9.48live price unavailable
1d—
3d+16.4%
1w-19.3%
1m-19.3%
3m-63.5%
6m-68.1%
1y-84.0%
original post →
$PCSAr/pennystocksBullishbullish
u/Specialist_Self4672 · 389d ago2 prior · awaiting results

$PCSA has a potential $454M+ licensing deal on the table

PCSA signed a binding term sheet with Intact Therapeutics for PCS12852 worth over $454M in potential milestone and royalty payments, creating a significant disconnect between the microcap's current valuation and upside if the deal closes and the drug progresses through trials and commercialization.

At post $9.83live price unavailable
1d-3.6%
3d-3.6%
1w-8.4%
1m-22.1%
3m-65.0%
6m-70.8%
1y-84.5%
original post →
$PCSAr/pennystocksBullishbullish
u/Specialist_Self4672 · 390d ago2 prior · awaiting results

$PCSA – Processa Pharmaceuticals – Why I’m Bullish AF.🚀

Stock exhibits a repeated intraday dip-and-rebound pattern with support holding on higher timeframes. The consistent absorption of dips and subsequent gap-ups suggest institutional buying, indicating further upside potential.

At post $11.98live price unavailable
1d-18.0%
3d-20.9%
1w-14.4%
1m-36.1%
3m-71.8%
6m-76.6%
1y-88.7%
original post →

End of results.